Why the study?
Does LVAD support improve contractile strength and alter calcium-handling gene expression in patients with end-stage heart failure?
Does LVAD support improve contractile strength and alter calcium-handling gene expression in patients with end-stage heart failure?
LVAD support in end-stage heart failure reverses contractile dysfunction and induces reverse molecular remodeling by upregulating SERCA2a protein and improving calcium handling.
No takes yet. Share an insight, caveat, or question.
LVAD unloading may support reverse remodeling in end-stage HF; leaves open whether SERCA2a changes improve clinical outcomes.
Heerdt et al. (2000) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: